The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 188 participants.

Also called NCT04130737

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 188 participants (enrolled count) (from the registry)
Sponsor
  • Endologix Registry lists this organization as the lead sponsor
  • Syntactx Registry lists this organization as a collaborator
Registry
  • NCT NCT04130737
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04130737. Allocation not applicable; no masking; primary purpose treatment. Start 2018-08-13 (actual); primary completion 2023-01-06 (actual). Results posted on 2026-07-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study
Acronym
TORUS2
Condition
Peripheral Arterial Disease
Intervention (Device)
TORUS Stent Graft System
Lead sponsor
Endologix (class: industry)
Collaborator
Syntactx (class: research network)
Collaborator
PQ Bypass, Inc. (class: industry)

Record details

Record id
cardio:ct-nct04130737
Content hash
b98037ab601410c7879d9c16dc5a0ee7ce87be36ebaea321fc9426900caf1969